Figure 4 | Scientific Reports

Figure 4

From: The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain

Figure 4

Micro-CT and x-ray images illustrating the proximal part of the tibia of the five different treatment groups. Micro CT image captured post-mortem of (a) cancer-operated and treated with vehicle; (b) Cancer-operated and treated with 5 mg/kg dasatinib; (c) Cancer-operated and treated with 15 mg/kg dasatinib; (d) Sham-operated and treated with vehicle; and (e) Sham-operated and treated with 15 mg/kg dasatinib. X-ray images captured on day 22 post inoculation f) cancer-operated and treated with vehicle; (g) Cancer-operated and treated with 5 mg/kg dasatinib; (h) Cancer-operated and treated with 15 mg/kg dasatinib; (i) Sham-operated and treated with vehicle; and (j) Sham-operated and treated with 15 mg/kg dasatinib.

Back to article page